Princeton Global Asset Management’s GSK GSK Stock Holding History

Princeton Global Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.1K	Hold	822	–	–	0.01%	382
2026 Q1	$45.4K	Hold	822	–	–	0.01%	363
2025 Q4	$40.3K	Hold	822	–	–	0.01%	371
2025 Q3	$35.5K	Hold	822	–	–	0.01%	367
2025 Q2	$31.6K	Hold	822	–	–	0.01%	375
2025 Q1	$31.8K	Sell	822 -533	-39%	-$19.5K	0.01%	346
2024 Q4	$45.8K	Hold	1,355	–	–	0.01%	330
2024 Q3	$55.4K	Sell	1,355 -160	-11%	-$6.54K	0.01%	304
2024 Q2	$58.3K	Hold	1,515	–	–	0.01%	272
2024 Q1	$64.9K	Hold	1,515	–	–	0.02%	232
2023 Q4	$56.1K	Buy	1,515 +533	+54%	+$19.1K	0.01%	251
2023 Q3	$35.6K	Hold	982	–	–	0.01%	280
2023 Q2	$35K	Hold	982	–	–	0.01%	285
2023 Q1	$34.9K	Buy	982 +62	+7%	+$2.17K	0.01%	288
2022 Q4	$32K	Hold	920	–	–	0.01%	280
2022 Q3	$27K	Hold	920	–	–	0.01%	290
2022 Q2	$50K	Hold	920	–	–	0.02%	255
2022 Q1	$50K	Hold	920	–	–	0.01%	266
2021 Q4	$51K	Hold	920	–	–	0.01%	252
2021 Q3	$44K	Sell	920 -612	-40%	-$30.7K	0.01%	267
2021 Q2	$76K	Buy	1,532 +640	+72%	+$30.8K	0.02%	224
2021 Q1	$40K	Hold	892	–	–	0.01%	259
2020 Q4	$41K	Hold	892	–	–	0.01%	259
2020 Q3	$42K	Hold	892	–	–	0.02%	227
2020 Q2	$45K	Buy	892 +640	+254%	+$32.8K	0.01%	260
2020 Q1	$12K	Sell	252 -374	-60%	-$19.9K	0.01%	374
2019 Q4	$37K	Buy	626 +374	+148%	+$20.8K	0.02%	266
2019 Q3	$14K	Sell	252 -308	-55%	-$15.8K	0.01%	287
2019 Q2	$28K	Sell	560 -160	-22%	-$8.03K	0.02%	264
2019 Q1	$37K	Buy	+720	New	+$36K	0.03%	213

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Princeton Global Asset Management's GSK Position: Q2 2026 in Review

Princeton Global Asset Management held its GSK (GSK) position steady in Q2 2026 at 822 shares worth $43.1K. The position accounts for 0.01% of the portfolio, ranked #382.

Princeton Global Asset Management first reported a position in GSK in Q1 2019 and has held it in 30 quarters since. The position peaked at $76K in Q2 2021. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Princeton Global Asset Management held 822 shares of GSK worth $43.1K as of Q2 2026.
Princeton Global Asset Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #382 holding.
Princeton Global Asset Management first reported a position in GSK in Q1 2019 and has held it in 30 quarters since.
Princeton Global Asset Management's GSK position peaked at $76K in Q2 2021.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.